Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
In recent years, scaffold-free bio-3D printing using cell aggregates (spheroids) as "bio-inks" has attracted increasing attention as a method for 3D cell construction. Bio-3D printing uses a technique called the Kenzan method, wherein spheroids are placed one-by-one in a microneedle array (the "Kenzan") using a bio-3D printer. The bio-3D printer is a machine that was developed to perform bio-3D printing automatically. Recently, it has been reported that cell constructs can be produced by a bio-3D printer using spheroids composed of many types of cells and that this can contribute to tissue (re-)construction. This progress report summarizes the production and effectiveness of various cell constructs prepared using bio-3D printers. It also considers the future issues and prospects of various cell constructs obtained by using this method for further development of scaffold-free 3D cell constructions.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/adhm.201901831 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Natural Medicine and 3D Printing for Tissue Repair, Drug Delivery, and Wound Healing: Integrating Traditional Chinese Medicine Bio-Actives with Advanced Biomaterials.
Macromol Biosci
July 2025
State Key Laboratory for Modification of Chemical Fibers and Polymer Materials, College of Biological Science and Medical Engineering, Donghua University, Shanghai, P. R. China.
Integrating Traditional Chinese Medicine (TCM) bio-actives in 3D-printed scaffolds combines ancient pharmacology with advanced additive manufacturing strategies for bone repair, wound healing, and drug delivery. This review highlights Carthamus tinctorius for cranial angiogenesis, Radix Dipsaci for fracture healing, Pearl powder for bone-mimicking mineralization, and ginger-garlic extract-loaded osteogenic-antibacterial implant. Tailored drug releases (21 days for Nuciferine and 56 days for Berberine) and Pyritum-enhanced β-TCP scaffolds showing spatial engineering by doubling compressive strength.
View Article and Find Full Text PDFThe sculpting tool in bioprinting: research and application progress of sacrificial inks.
Front Bioeng Biotechnol
June 2025
Department of Plastic and Reconstructive Surgery, The Second People's Hospital of China, Three Gorges University The Second People's Hospital of Yichang, Hubei, China.
The core of bio-3D printing technology lies in the development and optimization of bio-inks. For a long time, researchers have been looking for bio-inks that can balance printability and cell function. However, traditional bio-inks often have limitations in meeting this balance, limiting the complexity and scale of printable structures.
View Article and Find Full Text PDFXenograft of bio-3D printed scaffold-free cartilage constructs derived from human iPSCs to regenerate articular cartilage in immunodeficient pigs.
Regen Ther
June 2025
Center for Regenerative Medicine Research, Faculty of Medicine, Saga University, Saga, Japan.
Arthroplasty is currently the only option for reconstruction of large articular cartilage defects, mainly due to osteoarthritis. However, reconstruction with artificial materials has several issues such as deterioration, foreign body reaction, and bacterial infection. This study established a new method for articular cartilage reconstruction that fundamentally solves the problems associated with artificial materials by creating scaffold-free cartilage constructs and implanting them into extensive osteochondral defects without artificial materials.
View Article and Find Full Text PDFResearch on individualized drug sensitivity detection technology based on bio-3D printing technology for precision treatment of gastrointestinal stromal tumors.
Open Life Sci
May 2025
Department of Gastrointestinal Surgery, Ningbo Medical Center Li Hui Li Hospital, Ningbo, Zhejiang, 315000, China.
This study aims to analyze and explore whether tumor biological three-dimensional printing (3DP) models can serve as reliable preclinical model research tools and assist in the personalized treatment of gastrointestinal stromal tumor (GIST) patients. Ten GIST cases admitted to our hospital from May 2024 to September 2024 were included in the personalized treatment group. Patient-derived GIST 3DP models were established, and treatment plans were selected based on the results of drug sensitivity tests.
View Article and Find Full Text PDFAdvances and Prospects in Using Induced Pluripotent Stem Cells for 3D Bioprinting in Cardiac Tissue Engineering.
Rev Cardiovasc Med
March 2025
Department of Cardiovascular Surgery, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, 215008 Suzhou, Jiangsu, China.
Background: Cardiovascular diseases remain one of the leading causes of death worldwide. Given the limited self-repair capacity of cardiac tissue, cardiac tissue engineering (CTE) aims to develop strategies and materials for repairing or replacing damaged cardiac tissue by combining biology, medicine, and engineering. Indeed, CTE has made significant strides since the discovery of induced pluripotent stem cells (iPSCs) in 2006, including creating cardiac patches, organoids, and chip models derived from iPSCs, thus offering new strategies for treating cardiac diseases.
View Article and Find Full Text PDF